Japanese | English

| Sitemap |

Investor Relations  |  Environmental and Social Report  |  about Eisai  |  Inquiry

Eisai Global Site Investor Relations Environmental and Social Report about Eisai VITAMIN E Potential Suppliers Inquiry

Understanding Eisai Company Introduction Video Annual Report 2008 Environmental and Social Report 2008			News Release List December 15, 2008 FDA Approves Sedative-Hypnotic Agent LUSEDRA™ Injection November 17, 2008 FDA Approves BANZEL™ (rufinamide) as Adjunctive Treatment for Lennox-Gastaut Syndrome November 11, 2008 Eisai Completes Alliance Agreement with TorreyPines Therapeutics for Genetic Research Programs to Discover Genes Associated with LOAD -New Agreement Signed for Eisai to Purchase Research Assets-
			What's New List December 26, 2008 Commitment & Passion for hhc “Beyond the doctor,there are always patients” December 24, 2008 Environmental and Social Report - Opinions from Stakeholders “Patients want their voices to be heard.(Mr. Norio Sasaki)” December 17, 2008 Environmental and Social Report - Opinions from Stakeholders “I hope Eisai becomes a good partner in bringing happiness to the individual and to society (Mr. Tomoyuki Mochizuki)”
			Information MORPHOTEK®, INC. Announces Research Agreement with The University of Pennsylvania to Develop Oncology Therapeutic Antibody Candidates (December 24, 2008) Corporate Governance Report updated (July 31, 2008)

Privacy Policy  |  Terms of Use  |  Accessibility